Seebri Breezhaler (Glycopyrronium)
Brand: Seebri Breezhaler
Active Ingredient(s): Glycopyrronium
Strength: 50 mcg
Pack Size: 3 x 10 Capsules
Store at room temperature.
DIN: 02394936
Manufacturer: Novartis Pharma Canada Inc. (Canada)
Alternatives:
$137.33
*A valid prescription is required for Rx items.
Description
Seebri Breezhaler (Glycopyrronium) is a bronchodilator agent. It is typically used to treat COPD (chronic obstructive pulmonary disease, a group of lung conditions that cause breathing difficulties). It may also have other uses.
Additional information
Seebri Breezhaler (Glycopyrronium) is typically used once daily. However, your doctor or pharmacist may have suggested a different schedule that is more appropriate for you. Important: Follow the instructions on the label. Do not use more of this product, or more often than prescribed. If you miss a dose, contact your pharmacist. Seebri Breezhaler capsules must be administered only by the oral inhalation route and only using the Seebri Breezhaler inhaler. Capsules must not be swallowed. Capsules must always be stored in the blister to protect from moisture, and only removed IMMEDIATELY before use. Discard any capsules that are exposed to air and not used immediately. WARNING: Use with caution in patients with cardiovascular (heart) problems. Use with caution in patients with renal (kidney) problems. Glycopyrronium is indicated for long-term maintenance treatment and not for acute symptoms (severe and sudden in onset) of COPD (chronic obstructive pulmonary disease, a group of lung conditions that cause breathing difficulties). In addition to its desired action, Seebri Breezhaler (Glycopyrronium) may cause some side effects, notably: It may cause fatigue, upset stomach, indigestion, dry mouth It may cause nausea, vomiting, diarrhea and abdominal pain, symptoms of common cold (runny or stuffy nose, cough, sore throat, sneezing). It may cause pain in muscles, bones or joints, rash, tiredness, difficulty sleeping. Contraindications: Hypersensitivity to glycopyrrolate or any component of the formulation. Taking Seebri Breezhaler (Glycopyrronium) during pregnancy may be harmful for the baby. Women of childbearing potential should use an effective contraceptive method. Pregnant women should not use this product. If you're planning a pregnancy or become pregnant or breastfeeding, contact your family doctor. A treatment with Seebri Breezhaler (Glycopyrronium) requires regular monitoring by a doctor. Be sure to see your doctor for all regularly scheduled appointments.Seebri Breezhaler (Glycopyrronium)
Warning
Each person may react differently to a treatment. If you think this medication may be causing side effects (including those described here, or others), talk to your doctor or pharmacist. He or she can help you to determine whether or not the medication is the source of the problem.
There are no reviews yet.
Reviews